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Introduction
Family studies support a genetic contribution to Behçet’s
disease (BD), with a sibling recurrence-risk ratio of 11-
52. The class I MHC molecule, HLA-B*51 (B*51), is the
strongest known genetic risk factor for BD, however the
gene immediately centromeric to HLA-B, MICA, has also
been implicated in BD. Because of strong linkage disequi-
librium (LD) between HLA-B and MICA, their respective
contributions to BD susceptibility have been debated. A
recent report has proposed that B*51 is not a BD suscept-
ibility allele, and several studies have identified B*51-
independent association signals within the MHC.
Objectives
To clarify the relationship between B*51 and BD, and to
test for B*51-independent genetic variation within the
MHC that influences BD susceptibility.
Methods
Using Illumina Human 370CNV SNP genotypes in a
Turkish collection of 1244 BD patients and 1303 geogra-
phically-matched healthy subjects, we examined SNP
haplotypes and LD patterns across the HLA-B/MICA
region with Haploview. We performed SNP imputation
of the MHC using IMPUTE2 and the 1000 Genomes
Phase 1 dataset. We inferred classical HLA types and
their amino acids using SNP2HLA. Association testing
and regression analyses were performed using SNPTEST
and SNP & Variation Suite 7.
Results
We identified a B*51(+) HLA-B/MICA haplotype that
was strongly associated with BD (p=1.22E-46, OR 2.8).
A B*51(-) version of the same haplotype occurred at
equal frequencies in cases and controls, demonstrating
that B*51 is essential to the risk haplotype. Further, we
found that rs2848713, a variant on the MICA end of the
haplotype, conferred additional risk of BD in B*51(+)
individuals. Through imputation, we generated a set of
32,689 imputed SNPs. The 2 most strongly associated
SNPs were 4.8Kb centromeric of HLA-B (pmin=1.4E-50),
but no SNP was more strongly associated with BD than
was B*51 itself (p=1.3E-55). Conditioning on B*51
revealed an association near HLA-A (pmin=5.4E-9), and
upon adding a representative HLA-A SNP to the regres-
sion model, we detected residual association centromeric
of HLA-B (p=1.5E-5). Analysis of imputed HLA types
supported these findings. In addition to the association
of BD with B*51 (p=2.2E-55), sequential regression of
imputed HLA types identified associations of HLA-A*03
(p=1E-8), HLA-C*0701 (p=9.5E-4), and HLA-B*15
(p=1.2E-4) with BD. Stepwise forward regression of
imputed HLA-B amino acids identified 6 HLA-B resi-
dues that together fully accounted for the regional asso-
ciation at HLA-B.
Conclusion
This study affirms B*51 as the strongest risk factor of
BD. We have provided strong evidence opposing a
B*51-independent role for MICA variants in BD sus-
ceptibility. We have identified significant effects of
HLA-A*03 and HLA-C*0701, which protect against BD,
and HLA-B*15, which confers risk of BD. We have
identified a group of HLA-B amino acids, most of which
reside in the antigen binding groove, that together
account for the entire association signal at the HLA-B
locus.
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